Psoriasis Specimen BioBank

  • STATUS
    Recruiting
  • participants needed
    200
Send
Updated on 19 February 2024

Summary

The last 2 decades have witnessed a dramatic expansion in our understanding of the genetics, pathophysiology, and comorbidities of psoriasis leading to the development and approval of a variety of treatment strategies targeting pathways such as JAK/STAT, PDE4, TNF, IL12/23, and IL-17. We propose creating a biobank of specimens from patients with psoriatic disease (psoriasis and/or psoriatic arthritis).We propose prospectively collecting specimens from 200 patients with psoriatic disease, 18 years of age and older, able to provide consent, seen at PENN and deeply phenotyped clinically. All prospective participants will have had to wash out for a specified time from psoriasis medications to be eligible (see protocol for specified washout time frames). Such a biobank will be critical to allowing us to deepen and expand existing collaborations between dermatology, rheumatology, immunology, and genetics to better define the genetic and immunological abnormalities in psoriatic disease and conduct studies that lead to personalized medicine approaches to diagnosis, staging, and treatment selection for this common disease that affects over 7 million Americans.

Details
Condition Psoriasis
Age 18years - 99years
Clinical Study IdentifierN/A
Last Modified on19 February 2024

Eligibility

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.